NCT06861842View on ClinicalTrials.gov

Bioequivalence Study of Lithium Carbonate 300 mg Tablets. Actilitio® in Healthy Subjects

PHASE4Active, not recruitingINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

June 1, 2024

Primary Completion Date

April 30, 2025

Study Completion Date

April 30, 2025

Conditions
HealthyHealthy Donors
Interventions
DRUG

Theralite®

Reference

DRUG

Actilitio®

Test

Trial Locations (1)

111156

Centro de Atención e Investigación Médica, Bogotá

All Listed Sponsors
lead

Centro de Atencion e Investigacion Medica

NETWORK

NCT06861842 - Bioequivalence Study of Lithium Carbonate 300 mg Tablets. Actilitio® in Healthy Subjects | Biotech Hunter | Biotech Hunter